In estrogen receptor-positive (ER+) breast cancer, ChIP-seq shows estrogen receptor (ERα) enrichment at gained SEs in breast cancer over normal breast, including at the ESR1 SE itself which encodes ERα in an autoloop characteristic of SEs (Fig. 1) [7]. Here, ESR1 is linked to breast carcinoma.